Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
903.90
6.85 (0.76%) Clarification sought from Natco Pharma
Date: 23-06-2016The Exchange has sought clarification from Natco Pharma on June 23, 2016, with reference to new flashed on CNBC TV 18 stating ‘NATCO Pharma gets USFDA nod for Glycopyrrolate’.
The above information is a part of company’s filings submitted to BSE.